Bonesupport Holding AB (publ)
BONEX
Rank in Stocks
#5670
Bonesupport Holding AB (publ) is an orthobiologics company that specializes in... Bonesupport Holding AB (publ) is an orthobiologics company that specializes in the development and commercialization of injectable bioceramic bone graft substitutes. These products are utilized for treating bone voids and are available internationally, including in Europe and North America. Among its key offerings are CERAMENT Bone Void Filler, a synthetic, injectable, moldable, and drillable solution comprising hydroxyapatite, calcium sulfate, and the radio-contrast agent iohexol. Additionally, the company provides CERAMENT G, an injectable ceramic bone graft substitute infused with gentamicin, and CERAMENT V, a synthetic bone void filler containing vancomycin. Bonesupport is also advancing preclinical product candidates focused on promoting bone regrowth. These future solutions are being developed for applications such as trauma, revision arthroplasty, chronic osteomyelitis, oncology, and bone and foot infections related to diabetes. Founded in 1999, the company maintains its headquarters in Lund, Sweden.
Share Price
$33.08
Last synced: 2026-11-09
Market Cap
$2.16B
Change (1 day)
2.05%
Change (1 year)
47.73%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Bonesupport Holding AB (publ) (BONEX)
Category
Healthcare
Operating Margin for Bonesupport Holding AB (publ) (BONEX)
Operating Margin as of November 2026 TTM: 25.69%
According to Bonesupport Holding AB (publ)'s latest financial reports, its current operating margin (TTM) is 25.69%. At the end of 2025 the company had an operating margin of 23.55%.
Operating Margin history for Bonesupport Holding AB (publ) from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 25.69% | 9.09% |
| 2025 | 23.55% | 27.37% |
| 2024 | 18.49% | 683.47% |
| 2023 | 2.36% | -111.48% |
| 2022 | -20.56% | -48.25% |
| 2021 | -39.73% | -25.31% |
| 2020 | -53.19% | -47.57% |
| 2019 | -101.45% | -43.80% |
| 2018 | -180.50% | 135.06% |
| 2017 | -76.79% | -9.49% |
| 2016 | -84.84% | -2.81% |
| 2015 | -87.29% | -9.03% |
| 2014 | -95.95% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -99.41% |
US
|
|
| 18.08% | -99.30% |
IE
|
|
| 21.25% | -99.17% |
US
|
|
| 21.05% | -99.18% |
US
|
|
| 28.09% | -98.91% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Bonesupport Holding AB (publ)'s operating margin
What is Bonesupport Holding AB (publ)'s operating margin?
Bonesupport Holding AB (publ)'s operating margin is 25.69%, as of Nov 2026.
What was Bonesupport Holding AB (publ)'s operating margin in 2025?
In 2025, Bonesupport Holding AB (publ)'s operating margin was 23.55%, compared with 18.49% in 2024.
How has Bonesupport Holding AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Bonesupport Holding AB (publ)'s operating margin was highest in 2025 (23.55%) and lowest in 2020 (-53.19%).
How does Bonesupport Holding AB (publ)'s operating margin compare with similar companies?
Bonesupport Holding AB (publ)'s operating margin (25.69%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.